Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $51,196 | 29 | 48.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,075 | 26 | 35.0% |
| Travel and Lodging | $12,582 | 28 | 11.9% |
| Food and Beverage | $3,782 | 99 | 3.6% |
| Consulting Fee | $1,270 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $80,169 | 128 | $0 (2023) |
| Amgen Inc. | $25,299 | 45 | $0 (2024) |
| Allergan Inc. | $248.46 | 2 | $0 (2018) |
| Merz North America, Inc. | $71.84 | 2 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $28.63 | 2 | $0 (2022) |
| Hologic Sales and Service, LLC | $28.09 | 1 | $0 (2024) |
| AcelRx Pharmaceuticals, Inc. | $19.40 | 1 | $0 (2022) |
| Merz Pharmaceuticals, LLC | $14.70 | 1 | $0 (2022) |
| Genentech USA, Inc. | $13.34 | 1 | $0 (2022) |
| ABBVIE INC. | $13.32 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,327 | 46 | Amgen Inc. ($25,299) |
| 2023 | $33,517 | 61 | Horizon Therapeutics plc ($33,517) |
| 2022 | $21,720 | 42 | Horizon Therapeutics plc ($21,631) |
| 2021 | $18,747 | 20 | Horizon Therapeutics plc ($18,747) |
| 2020 | $1,325 | 2 | Horizon Therapeutics plc ($1,325) |
| 2019 | $4,949 | 9 | Horizon Therapeutics plc ($4,949) |
| 2018 | $150.85 | 2 | Allergan Inc. ($123.09) |
| 2017 | $169.45 | 2 | Allergan Inc. ($125.37) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,125.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $3.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/24/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $425.00 | General |
| 06/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Travel and Lodging | Cash or cash equivalent | $24.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/31/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/31/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $425.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $51.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $425.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Travel and Lodging | In-kind items and services | $648.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/08/2024 | Hologic Sales and Service, LLC | CoolSeal Generator (Device) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Surgical | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 727 | 814 | $408,554 | $90,348 |
| 2022 | 17 | 756 | 861 | $366,828 | $127,987 |
| 2021 | 15 | 743 | 819 | $318,297 | $120,743 |
| 2020 | 4 | 207 | 221 | $41,492 | $15,665 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67904 | Repair of tendon of upper eyelid | Office | 2023 | 15 | 16 | $55,995 | $13,732 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 147 | $26,979 | $10,812 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $44,028 | $10,757 | 24.4% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 36 | 37 | $38,527 | $9,671 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 86 | $22,335 | $9,423 | 42.2% |
| 67908 | Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | Facility | 2023 | 14 | 14 | $45,268 | $7,844 | 17.3% |
| 67924 | Extensive repair of turning-inward eyelid defect | Office | 2023 | 12 | 12 | $31,752 | $7,709 | 24.3% |
| 68810 | Insertion of probe into nasal tear duct | Office | 2023 | 35 | 37 | $61,175 | $7,197 | 11.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $24,933 | $5,034 | 20.2% |
| 92285 | Photography of content of eyes | Office | 2023 | 156 | 175 | $30,975 | $3,524 | 11.4% |
| 67800 | Removal of chronic growth of eyelid | Office | 2023 | 12 | 13 | $6,591 | $1,481 | 22.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 26 | 30 | $4,938 | $1,211 | 24.5% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 47 | 47 | $7,819 | $1,203 | 15.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 16 | 16 | $3,797 | $720.86 | 19.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 43 | $3,443 | $28.56 | 0.8% |
| 67904 | Repair of tendon of upper eyelid | Office | 2022 | 22 | 26 | $67,202 | $23,454 | 34.9% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2022 | 22 | 24 | $42,719 | $15,251 | 35.7% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2022 | 21 | 22 | $31,079 | $10,627 | 34.2% |
| 67908 | Removal of tissue, muscle, and membrane to correct eyelid drooping or paralysis | Facility | 2022 | 21 | 21 | $29,838 | $9,261 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $23,840 | $8,826 | 37.0% |
| 67917 | Extensive repair of turning-outward eyelid defect | Office | 2022 | 13 | 13 | $32,904 | $8,416 | 25.6% |
| 68810 | Insertion of probe into nasal tear duct | Office | 2022 | 34 | 38 | $18,446 | $7,786 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 102 | $17,231 | $7,783 | 45.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 86 | 101 | $20,270 | $6,985 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 70 | 70 | $17,523 | $6,503 | 37.1% |
About Dr. Sathyadeepak Ramesh, M.D
Dr. Sathyadeepak Ramesh, M.D is a Ophthalmology healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1053687004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sathyadeepak Ramesh, M.D has received a total of $105,905 in payments from pharmaceutical and medical device companies, with $25,327 received in 2024. These payments were reported across 184 transactions from 10 companies. The most common payment nature is "Honoraria" ($51,196).
As a Medicare-enrolled provider, Ramesh has provided services to 2,433 Medicare beneficiaries, totaling 2,715 services with total Medicare billing of $354,744. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery
- Location Somerset, NJ
- Active Since 03/23/2012
- Last Updated 01/30/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053687004
Products in Payments
- TEPEZZA (Drug) $75,220
- TEPEZZA (Biological) $24,874
- Xeomin (Biological) $58.78
- Seglentis (Drug) $28.63
- CoolSeal Generator (Device) $28.09
- XEOMIN (Biological) $27.76
- DSUVIA (Drug) $19.40
- Erivedge (Biological) $13.34
- BOTOX (Biological) $13.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Somerset
Dr. Mark Henry, Md, MD
Ophthalmology — Payments: $49,116
Tasneem Shamim, M.d, M.D
Ophthalmology — Payments: $2,641
Roopinder Grewal, M.d, M.D
Ophthalmology — Payments: $949.65
Dr. Richard Angrist, Md, MD
Ophthalmology — Payments: $97.14
Dr. Iraj Shariat, M.d, M.D
Ophthalmology